Vbi Vaccines
(OTC) VBIV
Vbi Vaccines Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$9.41M
Net Income (TTM)
$82.98M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VBIV News
3 Top Healthcare Stocks Under $5
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vbi Vaccines
Industry
Biotechnology
Sector
Health CareEmployees
138
CEO
Jeff Baxter
Website
www.vbivaccines.comHeadquarters
Cambridge, MA 02142, US
VBIV Financials
Key Financial Metrics (TTM)
Gross Margin
-67%
Operating Margin
-6%
Net Income Margin
-11%
Return on Equity
-3%
Return on Capital
-5%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.82M
Operating Income
$55.31M
EBITDA
$82.78M
Operating Cash Flow
$60.88M
Capital Expenditure
$867.00K
Free Cash Flow
$61.75M
Cash & ST Invst.
$23.68M
Total Debt
$53.04M
Vbi Vaccines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.21M
+150.3%
Gross Profit
$1.51M
+50.9%
Gross Margin
-1.24%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
131
N/A
Net Income
$17.90M
+52.2%
EBITDA
$15.39M
+39.2%
Quarterly Fundamentals
Net Cash
$38.12M
-218.2%
Accounts Receivable
$1.74M
+16.9%
Inventory
$9.94M
+46.9%
Long Term Debt
$2.27M
-95.7%
Short Term Debt
$50.41M
+2456.1%
Return on Assets
-1.07%
N/A
Return on Invested Capital
-4.93%
N/A
Free Cash Flow
$11.92M
+46.3%
Operating Cash Flow
$11.77M
+45.7%